resTORbio to Present at the 2018 RBC Capital Markets Global Healthcare Conference
February 20, 2018 08:00 ET
|
resTORbio, Inc.
BOSTON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the...
resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 30, 2018 16:01 ET
|
resTORbio, Inc.
BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the...
resTORbio Announces Pricing of Initial Public Offering
January 25, 2018 19:55 ET
|
resTORbio, Inc.
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of...